Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory

Figure 1

Flow chart of TB/HIV patients from Minsk, Belarus, enrolled into the TB : HIV study during 2011-2013, who have Mycobacterium tuberculosis (Mtb) culture samples available and with various drug susceptibly tests performed on these samples. Abbreviations: DST = drug-susceptibility testing; LPA = line probe assay; WGS = whole-genome sequencing. Patients were enrolled and followed up from the Republican Scientific and Practical Center for Pulmonology and TB, Minsk, Belarus. Mtb cultures were sent to the WHO TB Supranational Reference Laboratory, Copenhagen, Denmark, where drug-susceptibility testing was performed using phenotypic, LPA, and WGS methods.